Actively Recruiting
Muscle Mass Via UltraSound in Cirrhosis (MMUSCLE)
Led by University Hospital, Antwerp · Updated on 2026-05-01
60
Participants Needed
1
Research Sites
203 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational cohort study is to learn about loss of muscle mass and muscle strength (sarcopenia) in patients with cirrhosis. The main question\[s\] it aims to answer are: * what is the prevalence and development of sarcopenia in cirrhosis? * what is the role of malnutrition? Participants will * undergo a muscle ultrasound of the lower and upper limb muscles * handgrip strength will be measured * malnutrition screening and assessment * complete a questionnaire to assess quality of life
CONDITIONS
Official Title
Muscle Mass Via UltraSound in Cirrhosis (MMUSCLE)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of cirrhosis and follow-up at the University Hospital of Antwerp
You will not qualify if you...
- Patient refuses to participate or refuses study procedures
- Decision made to stop treatment within the next 24 hours
- No complete remission of cancer, including hepatocellular carcinoma, within the past 12 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Antwerp
Edegem, Antwerpen, Belgium, 2650
Actively Recruiting
Research Team
K
Karolien Dams, MD
CONTACT
S
Stany Perkisas, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here